People who used GLP-1 medications including Ozempic, Trulicity, Wegovy, Saxenda, Victoza, Mounjaro, Rybelsus, or Zepbound and were diagnosed with NAION or experienced sudden vision loss in one eye may be eligible for compensation.
Updates for each drug are substantiated by the most recent data retrieved from citations in PubMed, primarily accessing the MEDLINE database of life sciences and biomedical references, along with key abstracts and key announcements
Tips for keeping the weight off Establish a consistent routine Creating a daily routine that includes regular meal times, exercise, and sleep can help maintain weight loss
OP36 Lusvertikimab, a first-in-class IL7 receptor antagonist, in moderate to severe Ulcerative Colitis: results of a multicenter, randomized, placebo-controlled phase II study